ABSTRACT
This review summarizes evidence that may enhance and influence clinical practice of women’s health. Supporting articles were identified by reviewing high-impact medical and women’s health journals published in 2017 and 2018. The chosen articles are pertinent to osteoporosis screening, hormonal contraceptive interactions with antibiotics, hormone replacement therapy in BRCA1 mutation carriers, breast cancer diagnosis using digital tomosynthesis, and risks of hormonal contraception.
- Copyright © 2019 The Cleveland Clinic Foundation. All Rights Reserved.
- Pelin Batur, MD, FACP, NCMP, CCD⇑
- Ob/Gyn & Women’s Health Institute, Cleveland Clinic
- Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- Steering Committee, Women’s Preventive Services Initiative, American College of Obstetricians and Gynecologists and US Department of Health and Human Services, Health Resources & Services Administration
- ADDRESS:
Pelin Batur, MD, Women’s Health Institute, A8-406, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; baturp{at}ccf.org
ABSTRACT
This review summarizes evidence that may enhance and influence clinical practice of women’s health. Supporting articles were identified by reviewing high-impact medical and women’s health journals published in 2017 and 2018. The chosen articles are pertinent to osteoporosis screening, hormonal contraceptive interactions with antibiotics, hormone replacement therapy in BRCA1 mutation carriers, breast cancer diagnosis using digital tomosynthesis, and risks of hormonal contraception.
- Copyright © 2019 The Cleveland Clinic Foundation. All Rights Reserved.